 | • レポートコード：QFJ1-4552 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、土着細菌＆ウイルス抗原の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クラミディア抗原、アデノウイルス抗原、ボレリア抗原、チクングニアウイルス抗原、クロストリジウム抗原、デングウイルス抗原）、用途別市場規模（ELISA、イムノアッセイ、SDS-PAGE、血球凝集、凝集反応）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・土着細菌＆ウイルス抗原の市場動向 ・企業の競争状況、市場シェア ・土着細菌＆ウイルス抗原の種類別市場規模と予測2016-2027（クラミディア抗原、アデノウイルス抗原、ボレリア抗原、チクングニアウイルス抗原、クロストリジウム抗原、デングウイルス抗原） ・土着細菌＆ウイルス抗原の用途別市場規模と予測2016-2027（ELISA、イムノアッセイ、SDS-PAGE、血球凝集、凝集反応） ・土着細菌＆ウイルス抗原の北米市場規模2016-2027（アメリカ、カナダ） ・土着細菌＆ウイルス抗原の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・土着細菌＆ウイルス抗原のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・土着細菌＆ウイルス抗原の中南米市場規模2016-2027（メキシコ、ブラジル） ・土着細菌＆ウイルス抗原の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BIO-RAD LABORATORIES INC.、Microbix Biosystems、SERION Immunologics、Aalto Bio Reagents Ltd、Enzo Life Sciences Inc.、Jena Bioscience GmbH、ROSS SOUTHERN LABORATORIES、The Native Antigen Company、Creative Diagnostics、TRINA BIOREACTIVES AG） ・結論 |
Native antigens are extracted in their natural form from the respective sources. As they undergo usual modifications in vivo, upon isolation, they exhibit close resemblance withthe complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications may include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.
Market Analysis and Insights: Global Native Bacterial and Viral Antigens Market
The global Native Bacterial and Viral Antigens market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Native Bacterial and Viral Antigens market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Native Bacterial and Viral Antigens market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Native Bacterial and Viral Antigens market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Native Bacterial and Viral Antigens market.
Global Native Bacterial and Viral Antigens Scope and Market Size
Native Bacterial and Viral Antigens market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Native Bacterial and Viral Antigens market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chlamydia Antigens
Adenovirus Antigens
Borrelia Antigens
Chikungunya Virus Antigens
Clostridium Antigens
Dengue Virus Antigens
Segment by Application
ELISA
Immunoassay
SDS-PAGE
Hemagglutination
Agglutination Test
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BIO-RAD LABORATORIES INC.
Microbix Biosystems
SERION Immunologics
Aalto Bio Reagents Ltd
Enzo Life Sciences Inc.
Jena Bioscience GmbH
ROSS SOUTHERN LABORATORIES
The Native Antigen Company
Creative Diagnostics
TRINA BIOREACTIVES AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Native Bacterial and Viral Antigens Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chlamydia Antigens
1.2.3 Adenovirus Antigens
1.2.4 Borrelia Antigens
1.2.5 Chikungunya Virus Antigens
1.2.6 Clostridium Antigens
1.2.7 Dengue Virus Antigens
1.3 Market by Application
1.3.1 Global Native Bacterial and Viral Antigens Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 ELISA
1.3.3 Immunoassay
1.3.4 SDS-PAGE
1.3.5 Hemagglutination
1.3.6 Agglutination Test
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Native Bacterial and Viral Antigens Market Perspective (2016-2027)
2.2 Native Bacterial and Viral Antigens Growth Trends by Regions
2.2.1 Native Bacterial and Viral Antigens Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Native Bacterial and Viral Antigens Historic Market Share by Regions (2016-2021)
2.2.3 Native Bacterial and Viral Antigens Forecasted Market Size by Regions (2022-2027)
2.3 Native Bacterial and Viral Antigens Industry Dynamic
2.3.1 Native Bacterial and Viral Antigens Market Trends
2.3.2 Native Bacterial and Viral Antigens Market Drivers
2.3.3 Native Bacterial and Viral Antigens Market Challenges
2.3.4 Native Bacterial and Viral Antigens Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Native Bacterial and Viral Antigens Players by Revenue
3.1.1 Global Top Native Bacterial and Viral Antigens Players by Revenue (2016-2021)
3.1.2 Global Native Bacterial and Viral Antigens Revenue Market Share by Players (2016-2021)
3.2 Global Native Bacterial and Viral Antigens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Native Bacterial and Viral Antigens Revenue
3.4 Global Native Bacterial and Viral Antigens Market Concentration Ratio
3.4.1 Global Native Bacterial and Viral Antigens Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Native Bacterial and Viral Antigens Revenue in 2020
3.5 Native Bacterial and Viral Antigens Key Players Head office and Area Served
3.6 Key Players Native Bacterial and Viral Antigens Product Solution and Service
3.7 Date of Enter into Native Bacterial and Viral Antigens Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Native Bacterial and Viral Antigens Breakdown Data by Type
4.1 Global Native Bacterial and Viral Antigens Historic Market Size by Type (2016-2021)
4.2 Global Native Bacterial and Viral Antigens Forecasted Market Size by Type (2022-2027)
5 Native Bacterial and Viral Antigens Breakdown Data by Application
5.1 Global Native Bacterial and Viral Antigens Historic Market Size by Application (2016-2021)
5.2 Global Native Bacterial and Viral Antigens Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Native Bacterial and Viral Antigens Market Size (2016-2027)
6.2 North America Native Bacterial and Viral Antigens Market Size by Type
6.2.1 North America Native Bacterial and Viral Antigens Market Size by Type (2016-2021)
6.2.2 North America Native Bacterial and Viral Antigens Market Size by Type (2022-2027)
6.2.3 North America Native Bacterial and Viral Antigens Market Size by Type (2016-2027)
6.3 North America Native Bacterial and Viral Antigens Market Size by Application
6.3.1 North America Native Bacterial and Viral Antigens Market Size by Application (2016-2021)
6.3.2 North America Native Bacterial and Viral Antigens Market Size by Application (2022-2027)
6.3.3 North America Native Bacterial and Viral Antigens Market Size by Application (2016-2027)
6.4 North America Native Bacterial and Viral Antigens Market Size by Country
6.4.1 North America Native Bacterial and Viral Antigens Market Size by Country (2016-2021)
6.4.2 North America Native Bacterial and Viral Antigens Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Native Bacterial and Viral Antigens Market Size (2016-2027)
7.2 Europe Native Bacterial and Viral Antigens Market Size by Type
7.2.1 Europe Native Bacterial and Viral Antigens Market Size by Type (2016-2021)
7.2.2 Europe Native Bacterial and Viral Antigens Market Size by Type (2022-2027)
7.2.3 Europe Native Bacterial and Viral Antigens Market Size by Type (2016-2027)
7.3 Europe Native Bacterial and Viral Antigens Market Size by Application
7.3.1 Europe Native Bacterial and Viral Antigens Market Size by Application (2016-2021)
7.3.2 Europe Native Bacterial and Viral Antigens Market Size by Application (2022-2027)
7.3.3 Europe Native Bacterial and Viral Antigens Market Size by Application (2016-2027)
7.4 Europe Native Bacterial and Viral Antigens Market Size by Country
7.4.1 Europe Native Bacterial and Viral Antigens Market Size by Country (2016-2021)
7.4.2 Europe Native Bacterial and Viral Antigens Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Native Bacterial and Viral Antigens Market Size (2016-2027)
8.2 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type
8.2.1 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type (2016-2027)
8.3 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application
8.3.1 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application (2016-2027)
8.4 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Region
8.4.1 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Native Bacterial and Viral Antigens Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Native Bacterial and Viral Antigens Market Size (2016-2027)
9.2 Latin America Native Bacterial and Viral Antigens Market Size by Type
9.2.1 Latin America Native Bacterial and Viral Antigens Market Size by Type (2016-2021)
9.2.2 Latin America Native Bacterial and Viral Antigens Market Size by Type (2022-2027)
9.2.3 Latin America Native Bacterial and Viral Antigens Market Size by Type (2016-2027)
9.3 Latin America Native Bacterial and Viral Antigens Market Size by Application
9.3.1 Latin America Native Bacterial and Viral Antigens Market Size by Application (2016-2021)
9.3.2 Latin America Native Bacterial and Viral Antigens Market Size by Application (2022-2027)
9.3.3 Latin America Native Bacterial and Viral Antigens Market Size by Application (2016-2027)
9.4 Latin America Native Bacterial and Viral Antigens Market Size by Country
9.4.1 Latin America Native Bacterial and Viral Antigens Market Size by Country (2016-2021)
9.4.2 Latin America Native Bacterial and Viral Antigens Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Native Bacterial and Viral Antigens Market Size (2016-2027)
10.2 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type
10.2.1 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type (2016-2027)
10.3 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application
10.3.1 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application (2016-2027)
10.4 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Country
10.4.1 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Native Bacterial and Viral Antigens Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BIO-RAD LABORATORIES INC.
11.1.1 BIO-RAD LABORATORIES INC. Company Details
11.1.2 BIO-RAD LABORATORIES INC. Business Overview
11.1.3 BIO-RAD LABORATORIES INC. Native Bacterial and Viral Antigens Introduction
11.1.4 BIO-RAD LABORATORIES INC. Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.1.5 BIO-RAD LABORATORIES INC. Recent Development
11.2 Microbix Biosystems
11.2.1 Microbix Biosystems Company Details
11.2.2 Microbix Biosystems Business Overview
11.2.3 Microbix Biosystems Native Bacterial and Viral Antigens Introduction
11.2.4 Microbix Biosystems Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.2.5 Microbix Biosystems Recent Development
11.3 SERION Immunologics
11.3.1 SERION Immunologics Company Details
11.3.2 SERION Immunologics Business Overview
11.3.3 SERION Immunologics Native Bacterial and Viral Antigens Introduction
11.3.4 SERION Immunologics Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.3.5 SERION Immunologics Recent Development
11.4 Aalto Bio Reagents Ltd
11.4.1 Aalto Bio Reagents Ltd Company Details
11.4.2 Aalto Bio Reagents Ltd Business Overview
11.4.3 Aalto Bio Reagents Ltd Native Bacterial and Viral Antigens Introduction
11.4.4 Aalto Bio Reagents Ltd Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.4.5 Aalto Bio Reagents Ltd Recent Development
11.5 Enzo Life Sciences Inc.
11.5.1 Enzo Life Sciences Inc. Company Details
11.5.2 Enzo Life Sciences Inc. Business Overview
11.5.3 Enzo Life Sciences Inc. Native Bacterial and Viral Antigens Introduction
11.5.4 Enzo Life Sciences Inc. Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.5.5 Enzo Life Sciences Inc. Recent Development
11.6 Jena Bioscience GmbH
11.6.1 Jena Bioscience GmbH Company Details
11.6.2 Jena Bioscience GmbH Business Overview
11.6.3 Jena Bioscience GmbH Native Bacterial and Viral Antigens Introduction
11.6.4 Jena Bioscience GmbH Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.6.5 Jena Bioscience GmbH Recent Development
11.7 ROSS SOUTHERN LABORATORIES
11.7.1 ROSS SOUTHERN LABORATORIES Company Details
11.7.2 ROSS SOUTHERN LABORATORIES Business Overview
11.7.3 ROSS SOUTHERN LABORATORIES Native Bacterial and Viral Antigens Introduction
11.7.4 ROSS SOUTHERN LABORATORIES Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.7.5 ROSS SOUTHERN LABORATORIES Recent Development
11.8 The Native Antigen Company
11.8.1 The Native Antigen Company Company Details
11.8.2 The Native Antigen Company Business Overview
11.8.3 The Native Antigen Company Native Bacterial and Viral Antigens Introduction
11.8.4 The Native Antigen Company Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.8.5 The Native Antigen Company Recent Development
11.9 Creative Diagnostics
11.9.1 Creative Diagnostics Company Details
11.9.2 Creative Diagnostics Business Overview
11.9.3 Creative Diagnostics Native Bacterial and Viral Antigens Introduction
11.9.4 Creative Diagnostics Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.9.5 Creative Diagnostics Recent Development
11.10 TRINA BIOREACTIVES AG
11.10.1 TRINA BIOREACTIVES AG Company Details
11.10.2 TRINA BIOREACTIVES AG Business Overview
11.10.3 TRINA BIOREACTIVES AG Native Bacterial and Viral Antigens Introduction
11.10.4 TRINA BIOREACTIVES AG Revenue in Native Bacterial and Viral Antigens Business (2016-2021)
11.10.5 TRINA BIOREACTIVES AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Native Bacterial and Viral Antigens Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chlamydia Antigens
Table 3. Key Players of Adenovirus Antigens
Table 4. Key Players of Borrelia Antigens
Table 5. Key Players of Chikungunya Virus Antigens
Table 6. Key Players of Clostridium Antigens
Table 7. Key Players of Dengue Virus Antigens
Table 8. Global Native Bacterial and Viral Antigens Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Native Bacterial and Viral Antigens Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Native Bacterial and Viral Antigens Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Native Bacterial and Viral Antigens Market Share by Regions (2016-2021)
Table 12. Global Native Bacterial and Viral Antigens Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Native Bacterial and Viral Antigens Market Share by Regions (2022-2027)
Table 14. Native Bacterial and Viral Antigens Market Trends
Table 15. Native Bacterial and Viral Antigens Market Drivers
Table 16. Native Bacterial and Viral Antigens Market Challenges
Table 17. Native Bacterial and Viral Antigens Market Restraints
Table 18. Global Native Bacterial and Viral Antigens Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Native Bacterial and Viral Antigens Market Share by Players (2016-2021)
Table 20. Global Top Native Bacterial and Viral Antigens Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Native Bacterial and Viral Antigens as of 2020)
Table 21. Ranking of Global Top Native Bacterial and Viral Antigens Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Native Bacterial and Viral Antigens Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Native Bacterial and Viral Antigens Product Solution and Service
Table 25. Date of Enter into Native Bacterial and Viral Antigens Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Native Bacterial and Viral Antigens Revenue Market Share by Type (2016-2021)
Table 29. Global Native Bacterial and Viral Antigens Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Native Bacterial and Viral Antigens Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Native Bacterial and Viral Antigens Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Native Bacterial and Viral Antigens Revenue Market Share by Application (2016-2021)
Table 33. Global Native Bacterial and Viral Antigens Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Native Bacterial and Viral Antigens Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Native Bacterial and Viral Antigens Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Native Bacterial and Viral Antigens Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Native Bacterial and Viral Antigens Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Native Bacterial and Viral Antigens Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Native Bacterial and Viral Antigens Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Native Bacterial and Viral Antigens Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Native Bacterial and Viral Antigens Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Native Bacterial and Viral Antigens Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Native Bacterial and Viral Antigens Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Native Bacterial and Viral Antigens Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Native Bacterial and Viral Antigens Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Native Bacterial and Viral Antigens Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Native Bacterial and Viral Antigens Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Native Bacterial and Viral Antigens Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Native Bacterial and Viral Antigens Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Native Bacterial and Viral Antigens Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Native Bacterial and Viral Antigens Market Size by Country (2022-2027) & (US$ Million)
Table 65. BIO-RAD LABORATORIES INC. Company Details
Table 66. BIO-RAD LABORATORIES INC. Business Overview
Table 67. BIO-RAD LABORATORIES INC. Native Bacterial and Viral Antigens Product
Table 68. BIO-RAD LABORATORIES INC. Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 69. BIO-RAD LABORATORIES INC. Recent Development
Table 70. Microbix Biosystems Company Details
Table 71. Microbix Biosystems Business Overview
Table 72. Microbix Biosystems Native Bacterial and Viral Antigens Product
Table 73. Microbix Biosystems Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 74. Microbix Biosystems Recent Development
Table 75. SERION Immunologics Company Details
Table 76. SERION Immunologics Business Overview
Table 77. SERION Immunologics Native Bacterial and Viral Antigens Product
Table 78. SERION Immunologics Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 79. SERION Immunologics Recent Development
Table 80. Aalto Bio Reagents Ltd Company Details
Table 81. Aalto Bio Reagents Ltd Business Overview
Table 82. Aalto Bio Reagents Ltd Native Bacterial and Viral Antigens Product
Table 83. Aalto Bio Reagents Ltd Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 84. Aalto Bio Reagents Ltd Recent Development
Table 85. Enzo Life Sciences Inc. Company Details
Table 86. Enzo Life Sciences Inc. Business Overview
Table 87. Enzo Life Sciences Inc. Native Bacterial and Viral Antigens Product
Table 88. Enzo Life Sciences Inc. Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 89. Enzo Life Sciences Inc. Recent Development
Table 90. Jena Bioscience GmbH Company Details
Table 91. Jena Bioscience GmbH Business Overview
Table 92. Jena Bioscience GmbH Native Bacterial and Viral Antigens Product
Table 93. Jena Bioscience GmbH Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 94. Jena Bioscience GmbH Recent Development
Table 95. ROSS SOUTHERN LABORATORIES Company Details
Table 96. ROSS SOUTHERN LABORATORIES Business Overview
Table 97. ROSS SOUTHERN LABORATORIES Native Bacterial and Viral Antigens Product
Table 98. ROSS SOUTHERN LABORATORIES Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 99. ROSS SOUTHERN LABORATORIES Recent Development
Table 100. The Native Antigen Company Company Details
Table 101. The Native Antigen Company Business Overview
Table 102. The Native Antigen Company Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 103. The Native Antigen Company Recent Development
Table 104. Creative Diagnostics Company Details
Table 105. Creative Diagnostics Business Overview
Table 106. Creative Diagnostics Native Bacterial and Viral Antigens Product
Table 107. Creative Diagnostics Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 108. Creative Diagnostics Recent Development
Table 109. TRINA BIOREACTIVES AG Company Details
Table 110. TRINA BIOREACTIVES AG Business Overview
Table 111. TRINA BIOREACTIVES AG Native Bacterial and Viral Antigens Product
Table 112. TRINA BIOREACTIVES AG Revenue in Native Bacterial and Viral Antigens Business (2016-2021) & (US$ Million)
Table 113. TRINA BIOREACTIVES AG Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Native Bacterial and Viral Antigens Market Share by Type: 2020 VS 2027
Figure 2. Chlamydia Antigens Features
Figure 3. Adenovirus Antigens Features
Figure 4. Borrelia Antigens Features
Figure 5. Chikungunya Virus Antigens Features
Figure 6. Clostridium Antigens Features
Figure 7. Dengue Virus Antigens Features
Figure 8. Global Native Bacterial and Viral Antigens Market Share by Application: 2020 VS 2027
Figure 9. ELISA Case Studies
Figure 10. Immunoassay Case Studies
Figure 11. SDS-PAGE Case Studies
Figure 12. Hemagglutination Case Studies
Figure 13. Agglutination Test Case Studies
Figure 14. Native Bacterial and Viral Antigens Report Years Considered
Figure 15. Global Native Bacterial and Viral Antigens Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Native Bacterial and Viral Antigens Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Native Bacterial and Viral Antigens Market Share by Regions: 2020 VS 2027
Figure 18. Global Native Bacterial and Viral Antigens Market Share by Regions (2022-2027)
Figure 19. Global Native Bacterial and Viral Antigens Market Share by Players in 2020
Figure 20. Global Top Native Bacterial and Viral Antigens Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Native Bacterial and Viral Antigens as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Native Bacterial and Viral Antigens Revenue in 2020
Figure 22. Global Native Bacterial and Viral Antigens Revenue Market Share by Type (2016-2021)
Figure 23. Global Native Bacterial and Viral Antigens Revenue Market Share by Type (2022-2027)
Figure 24. North America Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Native Bacterial and Viral Antigens Market Share by Type (2016-2027)
Figure 26. North America Native Bacterial and Viral Antigens Market Share by Application (2016-2027)
Figure 27. North America Native Bacterial and Viral Antigens Market Share by Country (2016-2027)
Figure 28. United States Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Native Bacterial and Viral Antigens Market Share by Type (2016-2027)
Figure 32. Europe Native Bacterial and Viral Antigens Market Share by Application (2016-2027)
Figure 33. Europe Native Bacterial and Viral Antigens Market Share by Country (2016-2027)
Figure 34. Germany Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Native Bacterial and Viral Antigens Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Native Bacterial and Viral Antigens Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Native Bacterial and Viral Antigens Market Share by Region (2016-2027)
Figure 44. China Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Native Bacterial and Viral Antigens Market Share by Type (2016-2027)
Figure 52. Latin America Native Bacterial and Viral Antigens Market Share by Application (2016-2027)
Figure 53. Latin America Native Bacterial and Viral Antigens Market Share by Country (2016-2027)
Figure 54. Mexico Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Native Bacterial and Viral Antigens Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Native Bacterial and Viral Antigens Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Native Bacterial and Viral Antigens Market Share by Country (2016-2027)
Figure 60. Turkey Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Native Bacterial and Viral Antigens Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. BIO-RAD LABORATORIES INC. Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 64. Microbix Biosystems Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 65. SERION Immunologics Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 66. Aalto Bio Reagents Ltd Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 67. Enzo Life Sciences Inc. Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 68. Jena Bioscience GmbH Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 69. ROSS SOUTHERN LABORATORIES Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 70. The Native Antigen Company Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 71. Creative Diagnostics Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 72. TRINA BIOREACTIVES AG Revenue Growth Rate in Native Bacterial and Viral Antigens Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…- 世界のウイルスベクター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Vectors Market The global Viral Vectors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brillia…
- 世界の節足動物媒介性ウイルス感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Arthropod-borne Viral Infections Testing Market The global Arthropod-borne Viral Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界のウイルス性疾患診断市場規模・現状・予測（2021年-2027年） Viral Disease Diagnosis is based on clinical features and pathological data to determine the possible infection of viruses. Then according to the biological characteristics of suspicious viruses, immune response and clinical process, combined with the patient's current time. Market Analysis and Insi…
- 世界の水産養殖における細菌診断市場規模・現状・予測（2021年-2027年） At present aquaculture industries are one of the fastest growing industries in the globe. Unlike other livestock animals, aquatic animals also require proper attention in order to maintain their sound health. Careful deliberation required to select the rapid bacterial diagnostics in aquaculture meth…